The roles of non-coding RNAs in vascular calcification and opportunities as therapeutic targets

Juhee Ryu1, Youngkeun Ahn2, Hyun Kook3

  • 1Basic Research Laboratory for Vascular Remodeling, Chonnam National University Medical School, Jeollanam-do, Republic of Korea; Department of Biomedical Sciences, Center for Creative Biomedical Scientists at Chonnam National University, Jeollanam-do, Republic of Korea; Department of Biochemistry, Chonnam National University Medical School, Jeollanam-do, Republic of Korea; Department of Pharmacology, Chonnam National University Medical School, Jeollanam-do, Republic of Korea.

Pharmacology & Therapeutics
|September 10, 2020
PubMed

Insights

Non-coding RNAs (ncRNAs) are emerging regulators of vascular calcification (VC), a prevalent condition lacking approved therapies. Understanding ncRNAs offers new diagnostic and therapeutic avenues for VC.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Genetics

Background:

  • Vascular calcification (VC) involves calcium phosphate crystal accumulation in vessel walls, frequently linked to diabetes, chronic kidney disease (CKD), atherosclerosis, and cardiovascular disease (CVD).
  • Despite high prevalence, effective therapies for VC remain unavailable, highlighting the need for novel mechanistic insights.
  • While protein-coding RNAs in VC are well-studied, the role of non-coding RNAs (ncRNAs) is less understood.

Purpose of the Study:

  • To review and discuss the regulatory roles of various non-coding RNAs (ncRNAs) in vascular calcification (VC).
  • To explore the potential of ncRNAs as diagnostic markers and therapeutic targets for VC.
  • To elucidate novel mechanisms underlying VC pathogenesis involving ncRNAs.

Main Methods:

  • Literature review and synthesis of existing research on non-coding RNAs (ncRNAs) implicated in vascular calcification (VC).
  • Analysis of studies focusing on microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) in VC.
  • Discussion of the functional roles (promoter or inhibitor) of ncRNAs in VC development.

Main Results:

  • Accumulating evidence indicates that ncRNAs, including miRNAs, lncRNAs, and circRNAs, significantly regulate VC.
  • These ncRNAs can act as either promoters or inhibitors in the process of vascular calcification.
  • Dysregulation of specific ncRNAs is increasingly recognized as a key factor in VC pathogenesis.

Conclusions:

  • Non-coding RNAs (ncRNAs) represent a critical, yet understudied, class of molecules involved in vascular calcification (VC).
  • ncRNAs hold significant promise for the clinical diagnosis and development of novel therapeutic strategies for VC.
  • Further research into ncRNA mechanisms is essential for advancing VC treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
8.5K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
71.7K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K